Sign in
TerminatedPhase 4

Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis

Key facts

Who runs it
Bulovka Hospital
Where
Czechia2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
Phase
Phase 4
People taking part
61 people enrolled
Started
13 Jul 2021
Ended
1 Aug 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Cefixime 400mg
  • Benzathine penicillin 2.4 million units
Record updated
2 April 2025
Why it stopped
For financial and personnel reasons, patient recruitment was carried out in only one of the planned centers.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • 18 years of age or older
  • Non-pregnant, non breastfeeding
  • Able to provide informed consent
  • Clinically or laboratory-confirmed primary, secondary or early latent syphilis with a positive rapid treponemal test and an RPR/VDRL titer equal to or greater than 1:8
  • Non-cephalosporin allergic
  • Non-penicillin allergic
  • Agree to be occasionally called by study staff to be reminded to take study drug
  • Willing to attend follow-up visits

Who cannot take part

  • Prior history of syphilis in last two years
  • Systemic antibiotic therapy in last two weeks
  • Previous enrollment in the study
  • Allergy or contraindication to penicillin or cephalosporins (including allergy to cefixime)
  • Presenting a situation or condition that would not allow reliable study follow up (For example: frequent travel, alcohol abuse or substance misuse)
  • Under 18 years of age
  • Pregnancy, breastfeeding

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study evaluates the efficacy (non-inferiority) and safety of a new antibiotic treatment (cefixime), which has been previously used for single dose therapy of gonorrhoea in many years , in the treatment of early syphilis. Participants will be randomized to one of two study arms and will receive either expirimental regimen (cefixime) or the current standard antibiotic regimen (benzathine penicillin G). New treatment alternatives for syphilis could ensure that people are appropriately treated during periods or in settings of benzathine penicillin G stock out, penicillin allergy, or other intolerance to penicillin injection. This study may also identify an oral regimen for settings in which injections are not feasible.

The 2 groups in the trial

  • CefiximeTreatment being tested

    cefixime 400 mg taken orally two times a day for 14 consecutive days

    Treatment: Cefixime 400mg

  • benzathine penicillin GExisting treatment, for comparison

    benzathine penicillin G 2.4 MIU single dose intramuscularly

    Treatment: Benzathine penicillin 2.4 million units

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis - a Randomized, Multicentre, Non-inferiority, Open Label Trial
Record updated
2 April 2025